This weeks Items

[an error occurred while processing this directive]

Item #7 

Mix25 Insulin Mixture Gives Type 2’s Better Control Than Human Insulin 30/70

Mix25, a fixed mixture of 25 percent insulin lispro and 75 percent novel intermediate acting insulin, provides better postprandial plasma glucose control than does human insulin 30/70, without increasing the risk of exercised-induced hypoglycemia.

Matthias Herz and colleagues at the Eli Lilly and Company in Indianapolis, Indiana, United States, compared the plasma glucose response effects of Mix 25 and human insulin 30/70 on patients with type 2 diabetes.

The researchers treated 37 patients in a randomized, open-label, eight-week, two-period crossover study. Patients were injected with Mix25 five minutes before breakfast and dinner throughout the study. On inpatient test days and on outpatient dose titration days, they were injected instead with 30/70 human insulin five minutes before breakfast and dinner.

Following the four-week outpatient phase, patients were hospitalized and, three hours after a 339 kcal breakfast, were exercised at a heart rate of 120 beats per minute on a cycle ergometer two times for 30 minutes, separated by a 30 minute rest.

The two-hour postprandial plasma glucose levels of patients were significantly lower with Mix25 than with human insulin 30/70 (mean 10.5 mmol/l vs.11.6 mmol/l), the researchers reported. Maximum decrease in plasma glucose from onset of exercise to end of exercise was significantly less with Mix25 (mean -3.6 mmol/l vs -4.7 mmol/l). And the maximum decrease in plasma glucose levels over six hours after exercise onset was significantly less with Mix25 (-4.3 mmol/l vs -5.9 mmol/l).

"Mix25 resulted in better postprandial plasma glucose control without an increase in exercise-induced hypoglycemia," the researchers reported. "The smaller decrease in plasma glucose during the postprandial phase after exercise may suggest a lower risk of exercise-induced hypoglycemia with Mix25 than with human insulin 30/70, especially for patients in tight glycemic control."
Curr Med Res Opin 2002; 18: 188-193

 

================================

Medical Alert Watch: The long overdue alternative to traditional alert necklaces and ID bracelets.
Click Here

 

[an error occurred while processing this directive]

 

[an error occurred while processing this directive]

 


Get the FREE Diabetes In Control Newsletter!

  • * Free Diabetes Related Information.
  • * Participation in Current and Future Studies
  • * Participation in Surveys (honorariums)
  • * Information that better helps your patients.
  • * Stay Current with the most updated information on treatments and medical devices.
  • * Learn about new studies......plus much more...

Simply Enter your Email Address Below to begin receiving the FREE Diabetes In Control Weekly Newsletter in your mailbox.
 

Please specify the format you can receive the newsletter in below

HTML Text AOL

Home · About Us · Advertise · Classifieds · Current News · Downloads · Education · Features · Feedback · Links · New Products · Past Newsletters · Recommend Us · Search · Show All Stories · Studies · Subscribe · Test Your Knowledge · Tools For Your Practice · Writers Archives · Search Our Archives · NewsFeed

We subscribe to the HONcode principles of the Health On the Net Foundation

©Copyright 1999-2003 Diabetes In Control

For Questions about this website click here